See analyst estimates and all valuation multiples for Bioindustrials
| Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| $42.3B | 1.6x | 7.6x | |
| $17.9B | 4.0x | 15.3x | |
| $16.6B | 2.7x | 7.0x | |
| $12.9B | 0.9x | 5.7x | |
| $9.8B | 4.5x | 10.4x | |
| $9.3B | 3.1x | 8.5x | |
| $8.8B | 2.1x | 9.8x | |
| $6.5B | 3.0x | 9.1x | |
| $6.4B | 6.7x | 24.9x | |
| $2.8B | 0.8x | 108.2x | |
| $2.6B | 0.6x | 3.9x | |
| $2.1B | 2.4x | 13.6x | |
| $1.8B | 1.2x | 8.2x | |
| $1.3B | 2.5x | n/a | |
| $1.2B | 3.8x | 20.2x | |
| $699M | n/a | n/a | |
| $549M | 1.4x | 10.0x | |
| $460M | 1.9x | 12.1x | |
| $458M | 1.5x | 8.0x | |
| $295M | 0.6x | 1.9x | |
| $294M | 0.5x | 6.8x | |
| $190M | 3.1x | -4.1x | |
| $118M | 24.6x | -0.6x | |
| $77.8M | 478.4x | -13.3x | |
| $56.2M | 5.3x | 118.2x | |
| $43.2M | 2.8x | -6.8x | |
| $30.1M | n/a | n/a | |
| $28.9M | 7.6x | n/a | |
| $22.9M | 3.7x | -11.9x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Bioindustrials